HomeNERV • NASDAQ
add
Minerva Neurosciences Inc
Previous close
$1.47
Day range
$1.42 - $1.48
Year range
$1.15 - $3.69
Market cap
10.21M USD
Avg Volume
8.22K
P/E ratio
1.77
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 3.90M | 55.20% |
Net income | -3.75M | 56.20% |
Net profit margin | — | — |
Earnings per share | -0.50 | 55.75% |
EBITDA | -3.90M | 41.60% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 17.29M | -50.34% |
Total assets | 32.80M | -35.07% |
Total liabilities | 61.95M | -28.88% |
Total equity | -29.15M | — |
Shares outstanding | 6.99M | — |
Price to book | -0.35 | — |
Return on assets | -27.90% | — |
Return on capital | -29.95% | — |
Cash Flow
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -3.75M | 56.20% |
Cash from operations | -4.07M | 33.18% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -4.07M | 33.18% |
Free cash flow | -3.06M | 42.98% |
About
Founded
2007
Headquarters
Website
Employees
8